TABLE 3.
Summary of Efficacy Data in Patients Receiving Glofitamab by Dose Level and Histology as of August 3, 2020 (Primary Efficacy Population)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.